HOT OFF THE PRESS - Expand to view a selection of the most recent papers by CCBM mentors and mentees
Carrier protein mediated cargo sensing in quorum signal synthases
Arthanari lab, Chemical Communications, January 2023
Isolation of extracellular fluids reveals novel secreted bioactive proteins from muscle and fat tissues
Spiegelman and Chouchani Labs, Cell Metabolism, January 2023
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer
Dougan lab, Journal of Experimental Medicine, January 2023
The ETS transcription factor ETV6 constrains the transcriptional activity of EWS-FLI to promote Ewing sarcoma
Stegmaier Lab, Nature Cell Biology, January 2023
Architecture of the outbred brown fat proteome defines regulators of metabolic physiology
Chouchani lab, Cell, November 2022
BAF complex maintains glioma stem cells in pediatric H3K27M-glioma
Filbin and Qi labs, Cancer Discovery, November 2022
Congratulations to a CCBM Mentor, Kornelia Polyak, M.D., Ph.D. for her election to the prestigious National Academy of Medicine
Kornelia Polyak, M.D., Ph.D., professor of medicine, medical oncology, Dana-Farber Cancer Institute has been elected to the prestigious National Academy of Medicine. Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service. Read the full announcement here.
Study Points to Link Between Genetic Ancestry and Genetic Signature of Lung Cancer
A study led by one of our mentors, Dr. Matthew Meyerson, discovered that genetic ancestry can influence molecular signatures of lung cancer. The analysis included lung cancer tissue from more than 1,100 patients in Mexico and Colombia, and was published in the March 2022 issue of Cancer Discovery. Read more here!
Happy 75th Birthday Dana-Farber Cancer Institute!
Founded in 1947, Dana-Farber Cancer Institute, the home of our T32 Program, has been driving cancer care and transformative cancer research for 75 years now. The anniversary celebrations will continue throughout the year, and you can learn more about it here.
Congratulations to our past trainees on their fellowships:
- Narek Darabedia, PhD – National Cancer Center Fellowship
- Laura Stevens, PhD – The Helen Gurley Brown Fellowship
- Kedar Puvar, PhD – NIH Postdoctoral Fellowship (F32)
November 16, 2021
CCBM Mentors among world’s most highly cited researchers
Institute for Scientific Information at Clarivate has recently released their list of Highly Cited Researchers. The criteria for inclusion into this list is that a researcher needs to produce multiple papers ranking in the top 1% by citations for their field and year of publication.
We congratulate our mentors who have been included on this prestigious list: Myles Brown, MD; Benjamin Ebert, MD, PhD; Pasi Jänne, MD; Matthew Meyerson, MD, PhD; Margaret Shipp, MD; Bruce M. Spiegelman, PhD and Catherine J. Wu, MD.
Read the full press release here.
October 19, 2021
In Memoriam: David Morse Livingston, MD, Renowned Scientist and Esteemed Mentor
Dana-Farber community and many others in the field of cancer research were saddened by the unexpected death of David Morse Livingston, MD. Read more about Dr. Livingston’s impact on the field and his legacy here.
September 23, 2021
Congratulations to CCBM Mentor, Cigall Kadoch, Ph.D. for her selection as a Howard Hughes Medical Institute Investigator
Cigall Kadoch, Ph.D. was named as a Howard Hughes Medical Institute (HHMI) Investigator. The HHMI Investigator Program is a prestigious and highly selective program that funds cutting-edge scientists as they pursue most pressing questions in biomedical research.
Read full announcement here!
July 09, 2021
Metabolomics Facility at Dana-Farber wins Massachusetts Life Sciences Center funding
Congratulations to our co-director, Dr. Nika Danial for winning a $1.82 million grant from the Massachusetts Life Sciences Center to build a new cutting-edge metabolomics facility at Dana-Farber Cancer Institute. The Center will help accelerate basic and translational discoveries in the field of cancer and other disease, such as obesity, diabetes, neurologic disorders and inborn errors of metabolism. Read more about Dr. Danial’s plans for the new metabolomics facility here.
March 20, 2021
Bruce M. Spiegelman, PhD, receives 2021 Albert Renold Award, a major mentorship award
Congratulations to one of our mentors, Dr. Bruce Spiegelman for being named the recipient of the 2021 Albert Renold Award. This award is presented to an individual whose career is distinguished by outstanding achievements in the training and mentorship of diabetes research scientists and in the development of communities of scientists to enhance diabetes research. Read more about Dr. Spiegelman’s mentoring philosophy here.